SARPOGRELATE: 54 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
54
Total FAERS Reports
10 (18.5%)
Deaths Reported
34
Hospitalizations
54
As Primary/Secondary Suspect
4
Life-Threatening
2
Disabilities
First Report: 20011114 · Latest Report: 20230709
What Are the Most Common SARPOGRELATE Side Effects?
#1 Most Reported
Interstitial lung disease
4 reports (7.4%)
#2 Most Reported
Gastrointestinal haemorrhage
4 reports (7.4%)
#3 Most Reported
Spinal epidural haematoma
3 reports (5.6%)
All SARPOGRELATE Side Effects by Frequency
No side effect data available.
Who Reports SARPOGRELATE Side Effects? Age & Gender Data
Gender: 41.2% female, 58.8% male. Average age: 73.4 years. Most reports from: JP. View detailed demographics →
Is SARPOGRELATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 1 |
| 2010 | 1 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 6 | 0 | 5 |
| 2015 | 4 | 1 | 4 |
| 2016 | 1 | 1 | 1 |
| 2017 | 6 | 1 | 2 |
| 2018 | 5 | 1 | 4 |
| 2019 | 3 | 1 | 0 |
| 2020 | 4 | 0 | 4 |
| 2021 | 2 | 0 | 0 |
| 2023 | 2 | 0 | 1 |
What Is SARPOGRELATE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 15 |
| Peripheral arterial occlusive disease | 8 |
| Antiplatelet therapy | 7 |
Official FDA Label for SARPOGRELATE
Official prescribing information from the FDA-approved drug label.